–{•¶‚ÖƒXƒLƒbƒv

TEL. 058-230-6548

§501-1194 Šò•ŒŒ§Šò•ŒŽs–öŒË1-1

Œ¢–[@t•FINUFUSA Haruhiko

ƒvƒƒtƒB[ƒ‹

 Šw—ðF 1982”N
1988”N
1988”N`1990”N
‹ß‹E‘åŠw ˆãŠw•”‘²‹Æ
‹ß‹E‘åŠw ˆãŠw•”‘åŠw‰@ŠO‰ÈŠwŒnêU C—¹
•Ä‘ƒƒVƒ“ƒgƒ“B—§‘åŠw ¶‰»Šwi” Žçåˆê˜Nj‹³Žº ƒ|ƒXƒhƒN
 E—ðF 1991”N`2000”N
2001”N`2003”N
2004”N4ŒŽ`10ŒŽ
2004”N11ŒŽ`2005”N3ŒŽ
2005”N4ŒŽ`2006”N12ŒŽ
2007”N`2013”N10ŒŽ
2011”N`2013”N10ŒŽ
2013”N11ŒŽ`
‹ß‹E‘åŠw ˆãŠw•” uŽt
‹ß‹E‘åŠw ˆãŠw•”—Տ°ˆãŠw•”–å^—Տ°‰h—{Šw ‹³Žö
ƒXƒgƒ‰ƒXƒu[ƒ‹‘åŠw‰¢BƒeƒŒƒT[ƒWƒFƒŠ[Œ¤‹†Š ‹qˆõ‹³Žö
ƒXƒyƒCƒ“ƒoƒ‹ƒZƒƒi‘åŠwŠO‰ÈŠw‹³Žº ‹qˆõ‹³Žö
‹ß‹E‘åŠwˆãŠw•”æ’[ˆã—ÁEˆã—ÃŒoÏ‘΍ôŽº Žº’·
ƒuƒ‹ƒbƒNƒtƒB[ƒ‹ƒhƒƒfƒBƒJƒ‹Š”Ž®‰ïŽÐ ‘ã•\Žæ’÷–ð
TIMA JapanŠ”Ž®‰ïŽÐ ‘ã•\Žæ’÷–ð
Šò•Œ‘åŠw¶–½‰ÈŠwŒ¤‹†Žx‰‡ƒZƒ“ƒ^[ RŽ_‰»Œ¤‹†•”–å@•”–å’·



˜_•¶

 1. Iwasa, Z., Inufusa, H., Yamato, M., Takagi, H., Tanaka, A., Nakamura, T., Fukuhara, T., and Yasutomi, M. Immunohistochemical studies on estrogen receptor of scirrhus gastric cancer. Jpn J Gastroenterol Surg, 18, 1985.
 2. Onishi, H., Inufusa, H., Kurooka, K., Haeno, Y., Iwasa, Z., and Yasutomi, M. A case report of duodenal obstruction due to rupture of superior pancreaticoduodenal artery aneurysm. Med J Kinki Univ, 10: 317-326, 1985.
 3. Sagara, N., Inufusa, H., Haeno, Y., Kurooka, K., Hara, S., Nakai, T., Funai, S., Hida, J., Hirohata, k., Mori, N., Iwasa, Z., and Yasutomi, M. Measurement of a new tumor marker KM01-RPHA. Kisotorinsho, 19: 470-474, 1985.
 4. Sagara, N., Inufusa, H., Haeno, Y., Kurooka, K., Hara, S., Nakai, T., Funai, S., Hida, J., Hirohata, k., Mori, N., Iwasa, Z., and Yasutomi, M. Measurement of a new tumor marker KM01-RPHA. Kisotorinsho, 19: 470-474, 1985.
 5. Tanaka, A., Inufusa, H., Takagi, H., Hatta, M., Nakamura, T., Hamada, H., Izumoto, G., Iwasa, Z., and Yasutomi, M. Studies on lymph node metastasis of gastric cancer. Med J Kinki Univ, 10: 271-279, 1985.
 6. Yasutomi, M., Inufusa, H., and Iwasa, Z. Suture and anastomosis of the digestive canal. Semin Gastroenterol Surg, 19: 251-265, 1985.
 7.  Inufusa, H., Sagara, N., Hara, S., Sakaguchi, T., Tkagi, H., Tanaka, A., Hamada, H., Okuno, K., Iwasa, Z., and Yasutomi, M. Establishment of nude mice serially transplantable human stomach cancer KUMMK-2 producing plural tumor marker. Jpn J Gastroenterol, 83: 2264, 1986.
 8.  Inufusa, H., Sagara, N., Takagi, H., Yamato, M., Hamada, H., Okuno, K., Iwasa, Z., and Yasutomi, M. Experimental measurement of a new tumor marker KM01 -comparative study with CA19-9, CEA and IPA-. J Jpn Soc Clin Surg, 47: 1568-1573, 1986.
 9.  Iwasa, Z., Inufusa, H., Takagi, H., Tanaka, A., Nakamura, T., Fukuhara, T., and Yasutomi, M. Immunohistochemical studies on estrogen receptor of gastric cancers. Jpn J Gastroenterol Surg, 19: 1706-1710, 1986.
 10.  Iwasa, Z., Matsunami, N., Takagi, H., Tanaka, A., Inufusa, H., Hamada, H., and Yasutomi, M. Immunohistochemical studies on estrogen receptors in gastric cancer by immunoperoxidase technique. Acta Med Kinki Univ, 11: 129-134, 1986.
 11.  Inufusa, H. Characterization and metastatic study in nude mouse of human lung adenocarcinoma cell line KUMLK-2. Med J Kinki Univ, 12: 631-641, 1987.
 12.  Okuno, K., Nakamura, Y., Takagi, H., Kokudo, S., Onishi, H., Inufusa, H., Nakamura, T., Tanaka, A., Hamada, H., Iwasa, Z., and Yasutomi, M. Surface antigen analysis and anti-tumor activity of peritoneal exudate cells in the patients with gastric cancer and their modulating effect of OK432 pretreatment. Jpn J Gastroenterol Surg, 20: 1017-1021, 1987.
 13.   Sagara, N., Inufusa, H., Onishi, H., Haeno, Y., Hara, S., Kurooka, K., Kayama, H., and Yasutomi, M. Diagnostic value of tumor markers and combination assay with CEA, IAP, CA19-9, KM01 and CSLEX-1 for gastroenterological disease. Med J Kinki Univ, 11: 453-458, 1987.
 14.  Tanaka, A., Inufusa, H., Takagi, H., Hatta, M., Nakamura, T., Hamada, H., Izumoto, G., Iwasa, Z., and Yasutomi, M. Studies on the lymph node metastasis of gastric cancer and the sinus histiocytosis of lymph node by the clearing method. Jpn J Gastroenterol Surg, 20: 1837-1843, 1987.
 15.  Hamada, H., Tanaka, A., Takagi, H., Mori, N., Nakamura, Y., Inufusa, H., Nakamura, T., Shindo, K., and Yasutomi, M. A case report of disappearance of liver metastasis from gastric carcinoma treated with intra-arterial chemotherapy combined with OK-432. Med J Kiniki Univ, 13: 203-210, 1988.
 16.  Inufusa, H., Sagara, N., Nakano, K., Aizawa, M., and Yasutomi, M. Platelet aggregating activity and metastatic remission of human lung adenocarcinoma cell line KUMLK-2. Blood and Vessel, 19: 280-282, 1988.
 17.  Inufusa, H., Sagara, N., and Yasutomi, M. Characterization of the platelet aggregating material extracted from human lung cancer cell line which produce spontaneous lung metastasis in nude mice subcutaneous implantation. Blood and Vessel, 19: 283-286, 1988.
 18.  Inufusa, H. Establishment and characterization of human lung adenocarcinoma cell line KUM,LK-2 which produce spontaneous lung metastasis by nude mice subcutaneous implantation. J Jpn Surg Soc, 89: 1075-1082, 1988.
 19.  Mori, N., Inufusa, H., Aizawa, M., Nakano, K., Nakamura, Y., Nakamura, T., Hamada, H., Sagara, N., and Yasutomi, M. Experiences in measurement of tumor marker KM01-EIA, A comparative study with KM01-RPHA and CA19-9. Jpn J Gastroenterol Surg, 21: 2406-2410, 1988.
 20.  Sagara, N., Nakano, K., Aizawa, M., Hara, S., Inufusa, H., Mori, N., Kurooka, K., Haeno, Y., and Yasutomi, M. Influence of fosfomycin combination on anti-tumor effect of CDDP. Jpn J Cancer Chemother, 15: 94-100, 1988.
 21.  Sagara, N., Inufusa, H., Nakano, K., Hara, S., Aizawa, M., Kurooka, K., Haeno, Y., and Yasutomi, M. Tissue plasminogen activator and the development of spontaneous lung metastasis in nude mice hosts of transplanted human lung cancer cells. Lung Cancer, 28: 843-847, 1988.
 22.  Dohi, T., Nores, G. A., H.Oguchi, Inufusa, H., and Hakomori, S.-i. GM3 lactone as an immunogen associate with melanoma: Effect of immunization with GM3 lactone on melanoma growth in vivo. In: Gangliosides and cancer, pp. 273-282. New York: VCH publisher, 1989.
 23.  Inufusa, H., Sagara, N., Yasutomi, M., and Matsuo, O. Absence of t-PA in spontaneous metastatic lesions induced by a newly established cell line. Thrombosis Research, 53: 395-400, 1989.
 24.  Nakano, K., Sagara, N., Inufusa, H., Aizawa, M., Hara, S., Mori, N., and Yasutomi, M. The effect of blood transfusion on tumor growth and metastasis formation -a nude mouse-human cancer cell model-. Human Cell, 2: 304-306, 1989.
 25.  Sagara, N., Inufusa, H., Nakano, K., Mori, N., Aizawa, M., Hara, S., Hirohata, K., and Yasutomi, M. Establishment and characterization of human lung cancer cell line KUMLK-2. Human Cell, 2: 397-399, 1989.
 26.  Mori, N., Sagara, N., Hara, S., Inufusa, H., and Yasutomi, M. Procoagulant activity of human cancer cell line. Japanese Journal of Thrombosis and Haemostasis, 1: 553-555, 1990.
 27.  Adachi, T., Inufusa, H., Mori, N., Hara, S., Sagara, N., Matsuda, T., and Yasutomi, M. Characterization and metastatic potential of a mouse adenocarcinoma cell line XK-4 which arose in nude mouse during the transplantation of human colon cancer cell line KUM.RK-4N. Jpn J Gastroenterol Surg, 24: 2982-2989, 1991.
 28.  Inufusa, H., Kojima, N., Yasutomi, M., and Hakomori, S.-i. Human lung adenocarcinoma cell lines with different lung colonization potential(LCP), and a correlation between expression of sialosyl dimeric Lex(defined by MAb FH6) and LCP. Clin.Expl.Metastasis, 9: 245-257, 1991.
 29.  Yasutomi, M., Inufusa, H., Hida, J., and Matsuda, T. Surgery for cancer of anal and anal canal. Operation, 45: 1481-1486, 1991.
 30.  Adachi, T. and Inufusa, H. Inhibition of liver metastasis of a adenocarcinoma using YIGSR and synthetic polypeptide -polymeric star burst YIGSR-. Med J Kinki Univ, 17: 83-94, 1992.
 31.  Hagiya, Y., Fukao, M., Ueshima, S., Izaki, S., Inufusa, H., Kamiishi, H., Okada, K., and Matsuo, O. Urokinase-type plasminogen activator and its specific receptor in high metastatic and non-metastatic cell lines derived a human lung adenocarcinoma. Thrombosis Res., 65: 449-456, 1992.
 32.  Inufusa, H., Hara, S., Mori, N., and Yasutomi, M. Establishment and characterization of a human squamous cell carcinoma cell line LK-52 which produce direct activator of coagulant factor X. Human Cell, 5: 287-291, 1992.
 33.  Yasutomi, M., Inufusa, H., and Shindo, K. Diagnosis and therapy for the recto-proctal disease 1. symptoms, pathogenesis and examination. Surgical Therapy, 66: 718-722, 1992.
 34.  Inufusa, H. Pathway and prevention of metastasis in colo-rectal cancer. Jpn J Clin Nursing, 19: 1052-1056, 1993.
 35.  Inufusa, H., Adachi, T., Suzuki, M., Kurimoto, M., and Yasutomi, M. Generation of monoclonal antibodies against a novel coagulant cancer antigen 1 (CCA-1) and it's expression on human cancer cell lines. Jpn J Thromb Haemost, 4: 232-236, 1993.
 36.   Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., and Yasutomi, M. Expression of a novel cancer antigen coagulant cancer antigen 1 (CCA-1) on various human cancers: preliminary report. J Jpn Surg Soc, 94: 1166, 1993.
 37.   Inufusa, H., Adachi, T., Mori, N., Nakamura, M., Hara, S., Shindo, K., Yasutomi, M., and Sasaki, T. Enhanced inhibitory effect of polymeric star burst formed YIGSR peptide on newly established nude mouse spontaneous adenocarcinoma metastatic model. Int J Oncology, 3, 1993.
 38.  Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., and Yasutomi, M. Expression of a novel cancer antigen coagulant cancer antigen 1 on colorectal cancers. Jpn J Gastroenterol Surg, 26: 2809-2815, 1993.
 39.  Inufusa, H. New procoagulant activity of coagulant cancer antigen 1 which defined on cancer cell surface. Jpn J Thromb Haemost, 4: 448-451, 1993.
 40.  Kinoshita, T., Inufusa, H., Morikawa, E., Kitaoka, M., Nakamura, M., Nagayama, K., Akabane, Y., Adachi, T., Shindo, K., and Yasutomi, M. A case report of a mucocele of the appendix with intussusception. Med J Kinki Univ, 18: 457-463, 1993.
 41.  Mori, N., Inufusa, H., Adachi, T., Hara, S., Sagara, N., and Yasutomi, M. Establishment of a human lung squamous cell carcinoma cell line LK-17, and characterization of procoagulant, platelet aggregation and metastatic potential. Human Cell, 6: 226-230, 1993.
 42.   Son, E., Inufusa, H., Nakamura, M., Kitaoka, M., Adachi, T., Akabane, Y., Morikawa, E., Shindo, K., and Yasutomi, M. A case report of enterocutaneous fistula due to appendectomy 22 years after surgery. Med J Kinki Univ, 18: 315-318, 1993.
 43.  Yasutomi, M. and Inufusa, H. Revision of general rules for clinical and pathological studies on cancer of the colon, rectum and anus. In: Practical Gastroenterology 5, pp. 185-189. Tokyo: Bunkodo, 1993.
 44.  Funai, S., Kurooka, K., Fujii, Y., Inufusa, H., Yamada, H., Imanishi, Y., Sato, S., Shindo, K., and Yasutomi, M. MultiCycleTM software for cell cycle analysis. Jpn J Cancer Chemother, 21: 102-107, 1994.
 45.  Morikawa, E., Yasutomi, M., Shindo, K., Matsuda, T., Mori, N., Hida, J., Kubo, R., Kitaoka, M., Nakamura, M., Fujimoto, K., Inufusa, H., Hatta, M., and Izumoto, G. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum, 37: 219-223, 1994.
 46.  Nakamura, M. and Inufusa, H. Role of laminin-binding lectin CBP35 in colorectal cancer liver metastasis. Med J Kinki Univ, 19: 537-551, 1994.
 47.  Nakamura, M., Inufusa, H., Adachi, T., Shindo, K., Yasutomi, M., and Matsuura, H. Expression of oncofetal and normal fibronectin in colorectal cancer -correlation with stage, liver metastasis and prognosis-. Jpn J Gastroenterol Surg, 27: 884-891, 1994.
 48.  Nakamura, M., Inufusa, H., Adachi, T., Shindo, K., and Yasutomi, M. Expression of laminin-binding lectin CBP35 in colorectal cancer: correlation with liver metastasis. Jpn J Gastroenterol, 91: 1272, 1994.
 49.  Adachi, T., Inufusa, H., Nakatani, Y., Nakamura, M., Funai, S., Shindo, K., and Yasutomi, M. Roll of the tissue factor and coagulant cancer antigen 1 in the procoagulant activity of colorectal cancer cell line. Jpn J Gastroenterol Surg, 28: 977, 1995.
 50.  Inufusa, H., Nakamura, M., Adachi, T., Nakatani, Y., Shindo, K., Yasutomi, M., and Matsuura, H. Localization of oncofetal and normal fibronectin in colorectal cancer. Cancer, 75: 2802-2808, 1995.
 51.  Inufusa, H., Adachi, T., Nakamura, M., Shindo, K., Yasutomi, M., and Kimura, Y. Inhibition of experimental metastasis of human adenocarcinoma by cilostazol, a platelet phosphodiesterase inhibitor. Oncology Report, 2: 1079-1083, 1995.
 52.  Kubo, R., Machidera, N., Fujimoto, K., Ieda, S., Hida, J., Inufusa, H., Watatani, M., Shindo, K., and Yasutomi, M. Adjuvant therapy of colorectal carcinoma. Surgical Therapy, 73: 65-69, 1995.
 53.  Watatani, M., Tokoro, T., Machidera, N., Ieda, S., Fujimoto, K., Hida, J., Kubo, R., Inufusa, H., Shindo, K., and Yasutomi, M. Management of early colorectal cancer. Gastroenterol Surg, 18: 739-744, 1995.
 54.  Watatani, M., Kitaoka, M., Kuroda, K., Kubo, R., Machidera, N., Ieda, S., Fujimoto, K., Hida, J., Inufusa, H., and Yasutomi, M. Prognostic predictors in colorectal cancer. Jpn J Cancer Chemother, 22: 1129-1134, 1995.
 55.  Watatani, M., Nishimura, K., Ieda, S., Fujimoto, K., Hida, J., Kubo, R., Inufusa, H., and Yasutomi, M. Control of patient one week after the surgery, colon resection. Clinical Surgery, 50: 118-122, 1995.
 56.  Hagiya, Y., Fukao, H., Ueshima, S., Okada, K., Inufusa, H., Kamiishi, H., and Matsuo, O. Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line. Clinca Chimica Acta, 253: 37-50, 1996.
 57.  Hagiya, Y., Fukao, H., Ueshima, S., Okada, K., Inufusa, H., Kamiishi, H., and Matsuo, O. Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line. Clinca Chimica Acta, 253: 37-50, 1996.
 58.  Inufusa, H. Malignant tumor and thrombosis-Mechanisms- Procoagulant. Thrombosis and Circulation, 4: 278-282, 1996.
 59.  Nakatani, Y., Inufusa, H., Hida, J.-i., Nakamura, T., and Yasutomi, M. A case of gas-producing liver abscess with sepsis. J Jpn Soc Clin Surg, 57: 145-149, 1996.
 60.  Nakatani, Y., Inufusa, H., Adachi, T., Nakamura, M., and Yasutomi, M. Role of tissue factor and coagulant cancer antigen 1 in the procoagulant activity of breast cancer cell line. Jpn J Thromb Haemost, 7: 451-456, 1996.
 61.  Adachi, T., Inufusa, H., Nakatani, Y., Wakano, T., and Yasutomi, M. Role of coagulant cancer antigen 1, tissue factor and HLA-DR in the procoagulant activity of human gastric cancer cell line. Jpn J Gastroenterol, 94: 513, 1997.
 62.  Huang, C.-L., Taki, T., Adachi, M., Yagita, M., Sawada, S., Takabayashi, A., Inufusa, H., Yoshie, O., and Miyake, M. MRP-1/CD9 and KA11/CD82 expression in normal and various cancer tissues. International Journal of Oncology, 11: 1045-1051, 1997.
 63.  Nakatani, Y., Inufusa, H., and Adachi, T. Correlation between expression of coagulant cancer antigen 1 and prognosis of breast cancer patients. J Jpn Soc Cancer Ther, 32: 271-281, 1997.
 64.  Suzuki, M., Inufusa, H., Yamamoto, S., Hamada, T., Aga, M., Ando, O., Ohta, T., Yasutomi, M., and Kurimoto, M. Ley glycolipid acts as a co-factor for a tumor procoagulant activity. Int J Cancer, 73: 903-909, 1997.
 65.  Hashimoto, Y., Inufusa, H., Adachi, T., Funai, S., Wakano, T., Nakajima, A., Shindo, K., and Yasutomi, M. Ley expression and procoagulant activity of pancreas cancer cell line MIAPaCa-II induced by apoptosis. Jpn J Gastroenterol Surg, 31: 2181, 1998.
 66.  Hida, J.-i., Yasutomi, M., Maruyama, T., Wakano, T., Uchida, T., Fujimoto, K., Kubo, R., Inufusa, H., Uemura, H., and Shindo, K. Anterior resection following transsacral stapling and transection of the anal canal for low-lying rectal cancer in males. Surgery Today, 28: 768-769, 1998.
 67.  Inufusa, H., Adachi, T., Suzuki, M., Ando, O., Ohta, T., Kurimoto, M., Nakatani, Y., Nakamura, M., and Shindo, K. Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines. Cancer, 82: 1563-1569, 1998.
 68.  Inufusa, H., Nakatani, Y., Adachi, T., Wakano, T., Nakajima, A., Nakamura, M., Suzuki, M., Ando, O., Kurimoto, M., Miyake, M., Shindo, K., and Yasutomi, M. Correlation of prognosis of breast cancer patients and expression of Ley which acts as a cofactor of tumor procoagulant. International Journal of Oncology, 13: 481-487, 1998.
 69.  Wakano, T., Inufusa, H., Nkajima, A., Fujimoto, K., Hida, J.-i., Shindo, K., and Yasutomi, M. A case of simple ulcer of caecum which showed elevated lesion. Med J Kinki Univ, 23: 227-230, 1998.
 70.  Huang, C.-l., Kohno, N., Inufusa, H., Kodama, K., Taki, T., and Miyake, M. Overexpression of bax associated with Mutations in the loop-sheet-helix motif of p53. Am J Patology, 155: 955-965, 1999.
 71.   Inufusa, H., Kayama, H., and Yasutomi, M. Technique of laparoscopic surgery for colorectal cancer. Gastroenterological Surgery (Shokakigeka), 22: 163-171, 1999.
 72.  Inui, H., Inufusa, H., Watatani, M., and Yasutomi, M. Laparoscopic surgery of birateral adrenalectomy for birateral pheochromocytoma of MEN IIa. Operation (Shujutu), 6: 813-816, 1999.
 73.  Nakamura, M., Inufusa, H., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Nakajima, A., Hida, J.-i., Miyake, M., Shindo, K., and Yasutomi, M. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol, 15: 143-148, 1999.
 74.  Suzuki, M., Ando, O., Ohta, T., Inufusa, H., Adachi, T., Yasutomi, M., and Kurimoto, M. High expression of glycosphingolipids involved in procoagulant activity of cancer cells. Oncology Report, 6: 113-115, 1999.
 75.  Huang, C.-l., Kohno, N., Inufusa, H., Kodama, K., Taki, T., and Miyake, M. Overexpression of bax associated with Mutations in the loop-sheet-helix motif of p53. Am J Patology, 155: 955-965, 1999.
 76.  Nakamura, M., Inufusa, H., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Nakajima, A., Hida, J.-i., Miyake, M., Shindo, K., and Yasutomi, M. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol, 15: 143-148, 1999.
 77.  Inufusa, H., Hitoshi, K. and Yasutomi, M. Technique of laparoscopic surgery for colorectal cancer. Gastroenterological Surgery, 22: 163-171, 1999.
 78.  Wakano, T., Inufusa, H., Adachi, T., and Nakatani, Y. Regulation of Lewis Y expression by transforming growth factor-ƒÀ1and blood coagulating activity in colorectal cancer. Med J Kinki Univ, 24: 283-291, 1999.
 79.  Adachi, M., Taki, T., Higashiyama, M., Kohno, N., Inufusa, H., and Miyake, M. Significance of Integlin ƒ¿5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clinical Cancer Research, 6: 96-101, 2000.
 80.  Fukao, H., Ikeda, M., Ichikawa, T., Inufusa, H., Okada, K., Ueshima, S., and Matsuo, O. Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines. Clin Chim Acta., 296: 17-33, 2000.
 81.  Konishi, T., Huang, C.-L., Adachi, M., Taki, T., Inufusa, H., Kodama, K., Kohno, N., and Miyake, M. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancer. International Journal of Oncology, 16: 501-511, 2000.
 82.  Miyake, M., Inufusa, H., Adachi, M., Ishida, H., Hashida, H., Tokuhara, T., and Kakehi, Y. Suppression of pulmonary metastasis using adenovirally motility related protein (MRP1/CD9) gene delivery. Oncogene, 19: 5221-5226, 2000.
 83.  Inufusa, H., Ueda, K., Kawabe, T., and Yasutomi, M. New Wound Protector for Laparoscopic Colorectal Surgery. Journal of Japan society for endoscopic surgery, 5: 361-363, 2000.
 84.  Inufusa, H., Adachi, T., Nakatani, Y., Wakano, T., Nakamura, M., Okuno, K., Shiozaki, H., Yamamoto, S., Suzuki, M., Ando, O., Kurimoto, M., Miyake, M., and Yasutomi, M. Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. Int J Oncol, 19:941-946, 2001.
 85.  Inufusa, H., Nakamura, M., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Miyake, M., Okuno, K., Shiozaki, H., and Yasutomi, M. Role of Galectin-3 in Adenocarcinoma Liver Metastasis. Int J Oncol, 19:913-919, 2001

Šw‰ï‹y‚юЉï‚É‚¨‚¯‚銈“®“™

  “ú–{Á‰»Ší•aŠw‰ï@ê–åˆã@•]‹cˆõi‹ß‹E’n•û‰ïj 
“ú–{ŠO‰ÈŠw‰ï@”F’èˆã
“ú–{Á‰»ŠíŠO‰ÈŠw‰ï@”F’èˆã
“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï@•]‹cˆõ
“ú–{ŠàŽ¡—Êw‰ï@‰ïˆõ
•Ä‘ŠàŠw‰ïiAACRj‰ïˆõ
‘Û‘åŠw‘å’°Œ‹’°ŠO‰ÈŠw‰ïiISUCRSj@‰ïˆõ
“ú–{R‰Á—îˆãŠw‰ï@‰ïˆõ
“ú–{Ž_‰»ƒXƒgƒŒƒXŠw‰ï@‰ïˆõ

Ü”±

 •½¬6”N2ŒŽ
•½¬9”N4ŒŽ
•½¬10”N7ŒŽ
à’c–@l‘åã‘΃Kƒ“‹¦‰ï•½¬‚T”N“xŒ¤‹†•¬§—ã
“ú–{Á‰»Ší•aŠw‰ïŒ¤‹†§—ãÜ
‹ß‹E‘åŠwˆãŠw‰ïÜ


Šò•Œ‘åŠw ¶–½‰ÈŠw‘‡Œ¤‹†Žx‰‡ƒZƒ“ƒ^[ RŽ_‰»Œ¤‹†•”–å

§501-1194
Šò•ŒŒ§Šò•ŒŽs–öŒË1-1
ˆãŠw•”“7ŠK 7S33

TEL 058-230-6548
FAX 058-230-6549